Selvita S.A. Logo

Selvita S.A.

Preclinical CRO offering integrated drug discovery and development services for life sciences.

SLV | WAR

Overview

Corporate Details

ISIN(s):
PLSLVCR00029 (+1 more)
LEI:
25940057WQ9YP5MOQF28
Country:
Poland
Address:
KRAKÓW PODOLE 79, 30-394 KRAKÓW
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Selvita S.A. is one of Europe's largest preclinical Contract Research Organizations (CROs), providing integrated services for the pharmaceutical, biopharmaceutical, and chemical industries. The company specializes in drug discovery and development, with a mission to bridge the gap between early discovery and the clinical stages. Selvita offers a comprehensive scope of solutions, including high-quality research and development support and advanced analytical services. It supports client projects across various therapeutic areas, helping to accelerate the development of new therapies for patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 19:13
Regulatory News Service
Otrzymanie zlecenia w ramach istotnej współpracy / Receipt of an Order as Part …
English 2.4 KB
2025-11-27 19:13
Regulatory News Service
Otrzymanie zlecenia w ramach istotnej współpracy / Receipt of an Order as Part …
Polish 2.0 KB
2025-11-25 17:41
Regulatory News Service
Zawarcie umowy o dofinansowanie w ramach programu FENG / Conclusion of the co-f…
Polish 1.0 KB
2025-11-25 17:14
Director's Dealing
Powiadomienie 2
Polish 5.2 KB
2025-11-25 17:14
Related Party Transaction
Powiadomienie 1
Polish 5.3 KB
2025-11-25 17:14
Major Shareholding Notification
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications f…
Polish 971 bytes
2025-11-21 17:19
Regulatory News Service
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Conte…
Polish 1.1 KB
2025-11-21 17:01
Related Party Transaction
19.1.MAR
Polish 4.4 KB
2025-11-21 17:01
Director's Dealing
19.1.MAR
Polish 4.3 KB
2025-11-21 17:01
Major Shareholding Notification
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications f…
Polish 952 bytes
2025-11-20 00:02
Quarterly Report
Jednostkowe sprawozdanie finansowe Q3 pdf
Polish 1022.9 KB
2025-11-20 00:02
Quarterly Report
Consolidated Financial Statements Q3 pdf
English 1.1 MB
2025-11-20 00:02
Regulatory News Service
Skonsolidowane sprawozdanie finansowe Q3 pdf
Polish 2.2 MB
2025-11-20 00:02
Quarterly Report
Selvita Capital Group Q3 Report pdf
English 7.9 MB
2025-11-20 00:02
Quarterly Report
Sprawozdanie Zarządu z działalności (Grupa Kapitałowa) Q3 pdf
Polish 8.0 MB

Automate Your Workflow. Get a real-time feed of all Selvita S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Selvita S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Selvita S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden
MVIR
Sweden
MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland
MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland
MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany
MOR
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel
NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France
COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom
ONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.